Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 28, 2009 Brian Orelli	The Streak Is Over After 31 consecutive quarters of double-digit sales growth, medical device maker Stryker finally had an off quarter.
The Motley Fool October 18, 2007 Billy Fisher	An Empire Strykes Back Stryker reports a quarter of double-digit growth in revenue and earnings. Investors, take note.
The Motley Fool July 18, 2008 Brian Orelli	What Strikes Against Stryker? High growth isn't enough to impress investors.
The Motley Fool July 23, 2010 Jordan DiPietro	Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider?
The Motley Fool January 31, 2006 Stephen D. Simpson	Zimmer Muddles Through So long as the pressures in the orthopedic sector prove less than originally feared, investors could still make money here.
The Motley Fool July 23, 2009 Robert Steyer	Long Convalescence for Device Makers Orthopedic product specialists Stryker and Zimmer Holdings forecast a slow-motion recovery.
The Motley Fool July 26, 2007 Ryan Fuhrmann	Zimmer Simmers The maker of hip and knee replacements gets a leg up on the market. Investors, take note.
The Motley Fool October 27, 2005 Stephen D. Simpson	Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective.
The Motley Fool April 13, 2006 Stephen D. Simpson	A Foolish Baby Shower: Stryker Here is a stock you can be comfortable with buying for your little one with the intention that it would be held for at least 18 years.
The Motley Fool August 27, 2010 Brian Orelli	A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much.
The Motley Fool August 28, 2008 Brian Orelli	Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation.
The Motley Fool December 1, 2011 David Meier	Why I Am Buying MAKO Surgical MAKO Surgical is changing orthopedic surgery, one robot at a time.
The Motley Fool July 23, 2009 Brian Orelli	The Impressive Number No One Is Talking About Future growth still looks good for Intuitive Surgical.
The Motley Fool February 13, 2007 Jack Uldrich	I Love Intuitive Surgical Robotic surgeries should have investors' hearts pumping.
The Motley Fool July 20, 2007 Ryan Fuhrmann	Stryker Does a Body Good The orthopedics company continues its double-digit growth in an industry with a bright future. Investors, take note.
The Motley Fool February 9, 2006 Stephen D. Simpson	Growth Not Enough for Smith & Nephew This orthopedic company has market-leading growth, but just not enough cash flow. Investors shouldn't get too excited about these shares.
The Motley Fool September 5, 2008 Brian Orelli	Zimmer Fortifies Its Spine The medical-device maker is buying Abbott's spine business.
The Motley Fool April 28, 2006 Stephen D. Simpson	Of Intuition and Intuitive Surgical Price has decoupled from value, but the company is growing like a weed. Investors, take note.
The Motley Fool April 28, 2004 Glen Trematore	Zimmer Makes a Family Proud Zimmer Holdings looks strong when compared with other orthopedic/medical device makers.
The Motley Fool January 29, 2007 Matthew Crews	Only One Bone to Pick With Stryker With products for wherever you hurt, the med-tech company continues to deliver solid earnings.
The Motley Fool December 31, 2008 Brian Orelli	Medical Device Makers Are as Cheap as Ever Value investing, health-care style.
BusinessWeek November 12, 2007 Arlene Weintraub	Getting Hip to the Boomers Stryker's new orthopedic technology gives aging patients an alternative to full joint replacement.
The Motley Fool October 19, 2010 Brian Orelli	Watch a 40% Decline Disappear The greatest thing going for Johnson & Johnson is its diversity in product offerings.
The Motley Fool July 21, 2006 Stephen D. Simpson	Stryker and the Terror of the Unknown This has been a pretty bad year to be a good medical technology company. Fears about future pricing and the DOJ investigation keep a lid on the entire sector. So, what about that future for Stryker? Investors, take note.
The Motley Fool December 11, 2006 Jack Uldrich	Intuitive Surgical's Beating Heart Investors, there are a lot of reasons to like Intuitive Surgical. Better software will continue to improve surgeons' performance levels in meeting the demanding requirements of cardiovascular surgery.
The Motley Fool September 14, 2005 Stephen D. Simpson	Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance.
The Motley Fool April 21, 2006 Stephen D. Simpson	Stryker Strikes a Chord A solid quarter and generally positive guidance refuels investor enthusiasm.
The Motley Fool September 21, 2005 Stephen D. Simpson	Can Biomet Stay Limber? Concerns about pricing have buffeted the orthopedic space and the No. 4 player in hips and knees. Whatever the case turns out to be, Biomet is probably a bit riskier than average.
CRM February 2004 Lisa Picarille	Mobile CRM Helps Smith & Nephew Reps Customized applications allow sales reps to have all the resources, technical knowledge, and credibility of their product development department.
The Motley Fool May 28, 2004 Roger Nusbaum	Stryker Stands Out This is one medical equipment maker that looks good.
The Motley Fool April 16, 2004 Bill Mann	Stryker Hits It Again Stryker, the medical device company, reported year-over-year gains in revenues of 22%, with sales just over $1 billion. Earnings were even better: Stryker topped off last year's results by more than 30%.
The Motley Fool February 8, 2011 Brian Orelli	What Will Intuitive Surgical Do for an Encore? Intuitive Surgical managed just a 10% year-over-year increase in revenue from sales of its da Vinci Surgical Systems in the fourth quarter of last year. Yet its total revenue increased a solid 21%. How?
The Motley Fool August 10, 2011 Evan Niu	One Medical-Device Stock to Buy MAKO Surgical delivers strong results.
The Motley Fool April 29, 2011 David Williamson	Johnson & Johnson's Traumatic Purchase Johnson & Johnson agrees to purchase trauma and spine specialist Synthes.
The Motley Fool December 12, 2006 Matthew Crews	Smith & Nephew, What's the Deal? A merger with Biomet would be good in many ways. But what's the right price? Investors, take note.
The Motley Fool July 28, 2005 Stephen D. Simpson	Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples.
The Motley Fool July 20, 2005 Stephen D. Simpson	Stryker Delivers the Growth Med-tech company Stryker has been a consistent grower for years and shows no signs of slowing down. There will be bumps along the way, but Stryker is an interesting large-cap growth play.
The Motley Fool May 28, 2009 Anders Bylund	Of Robots and Rocket-Powered Returns Intuitive Surgical is a stock that meets your need for speed and security, all at once.
The Motley Fool July 25, 2011 Brian Stoffel	My Money Is On This Hot Medical Stock Intuitive Surgical is blazing new paths for surgical procedures.
The Motley Fool November 23, 2005 Rick Munarriz	Daily Double: Intuitive Surgical While growth investors may not balk at paying 69 times this year's profits for a dynamic growth company like Intuitive Surgical, they may think twice if a bottom line dip prices the company at nearly 80 times forward earnings.
The Motley Fool October 16, 2008 Brian Orelli	Foolish Forecast: Robots on the Cheap Intuitive Surgical releases earnings in a few hours. Here are some premonitions to tide you over as you anxiously wait the news.
The Motley Fool July 20, 2010 Jim Mueller	Buy, Sell, or Hold Intuitive Surgical? Coming into the quarterly earnings, what should investors do regarding Intuitive Surgical? Here's a quick look at some arguments for the three possibilities.
The Motley Fool October 25, 2007 Billy Fisher	Plenty of Strength in Zimmer Orthopedic manufacturer Zimmer Holdings reports a solid third quarter, but lowers its forecast for Q4.
BusinessWeek December 6, 2004 Kathleen Kerwin	Knees And Hips -- And Now What? Stryker may need more than artificial joints. Its CEO-to-be is betting on biotech.
The Motley Fool September 20, 2006 Ryan Fuhrmann	Biomet's Aching Joints Biomet operates in the appealing medical device industry, but current growth trends are giving investors a headache.
The Motley Fool July 27, 2006 Stephen D. Simpson	Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine.
The Motley Fool November 28, 2008 Brian Orelli	Bargain Stocks for Black Friday: Intuitive Surgical This is a company that's seen trailing-12-month revenue increase 59% year over year. No matter what you think of high-growth stocks, its 25 P/E is pretty darn cheap.
The Motley Fool August 24, 2010 Brian Orelli	Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm.
The Motley Fool November 11, 2011 Evan Niu	MAKO Surgical Is Breaking the Rules The company reports strong third-quarter revenue but still has yet to turn a profit.
Managed Care March 2007	Competition Wins Over Centralization Insurers who recommend a particular provider or health care organization to a patient considering a surgical procedure need to determine how complex the procedure is and how frequently the surgeon performs the procedure.